Comments
Actelion says lung drug macitentan submitted in Europe
23.11.2012. | ZURICH (Reuters) - Actelion has submitted heart and lung drug macitentan to European health regulators, the second major step for the drug the Swiss group is positioning as a viable successor to its current top seller....
